Cytokinetics Stock Price on November 20, 2025
| CYTK Stock | USD 65.79 0.75 1.13% |
If you're considering investing in Cytokinetics Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cytokinetics stands at 65.79, as last reported on the 5th of December, with the highest price reaching 65.79 and the lowest price hitting 65.79 during the day. Cytokinetics appears to be very steady, given 3 months investment horizon. Cytokinetics secures Sharpe Ratio (or Efficiency) of 0.15, which signifies that the company had a 0.15 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Cytokinetics, which you can use to evaluate the volatility of the firm. Please makes use of Cytokinetics' Downside Deviation of 2.61, risk adjusted performance of 0.1219, and Mean Deviation of 2.2 to double-check if our risk estimates are consistent with your expectations.
At this time, Cytokinetics' Stock Based Compensation is quite stable compared to the past year. Issuance Of Capital Stock is expected to rise to about 742.2 M this year, although the value of Common Stock will most likely fall to about 112.1 K. . At this time, Cytokinetics' Price To Sales Ratio is quite stable compared to the past year. Price Earnings To Growth Ratio is expected to rise to 2.69 this year, although the value of Price To Operating Cash Flows Ratio is projected to rise to (12.64). Cytokinetics Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Cytokinetics | Build AI portfolio with Cytokinetics Stock |
Price Book 60.3093 | Enterprise Value Ebitda (15.82) | Price Sales 93.2854 | Shares Float 121.7 M | Wall Street Target Price 79.5556 |
Cytokinetics Main Headline on 20th of November 2025
Cytokinetics Assessing Valuation After Fresh Legal Scrutiny ... by simplywall.st
Several law firms have recently filed securities class action lawsuits and launched investigations into Cytokinetics , claiming that the company misled investors about regulatory timelines and risks associated with FDA approval of its drug aficamten. This wave of legal scrutiny follows earlier positive clinical data releases, which has sharpened investor focus on the companys future disclosures and the broader regulatory process. See our latest analysis for Cytokinetics. Even as...
Cytokinetics Valuation on November 20, 2025
It is possible to determine the worth of Cytokinetics on a given historical date. On November 20, 2025 Cytokinetics was worth 65.38 at the beginning of the trading date compared to the closed value of 63.5. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cytokinetics stock. Still, in general, we apply an absolute valuation method to find Cytokinetics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cytokinetics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cytokinetics' related companies.
| Open | High | Low | Close | Volume | |
| 65.90 | 65.91 | 63.70 | 64.79 | 1,961,252 | |
11/20/2025 | 65.38 | 65.66 | 62.86 | 63.50 | 1,768,265 |
| 63.46 | 66.76 | 63.02 | 65.44 | 1,395,875 |
| Backtest Cytokinetics | | | Cytokinetics History | | | Cytokinetics Valuation | Previous | Next |
Cytokinetics Trading Date Momentum on November 20, 2025
| On November 21 2025 Cytokinetics was traded for 65.44 at the closing time. The top price for the day was 66.76 and the lowest listed price was 63.02 . The trading volume for the day was 1.4 M. The trading history from November 21, 2025 was a factor to the next trading day price upswing. The overall trading delta against the next closing price was 3.06% . The overall trading delta against the current closing price is 6.91% . |
Cytokinetics Fundamentals Correlations and Trends
By evaluating Cytokinetics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cytokinetics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cytokinetics financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cytokinetics Stock history
Cytokinetics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cytokinetics is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cytokinetics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cytokinetics stock prices may prove useful in developing a viable investing in Cytokinetics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 112 M | 117.6 M | |
| Net Loss | -350.1 M | -332.6 M |
Cytokinetics Quarterly Net Working Capital |
|
Cytokinetics Stock Technical Analysis
Cytokinetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Cytokinetics Period Price Range
Low | December 5, 2025
| High |
0.00 | 0.00 |
Cytokinetics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cytokinetics December 5, 2025 Market Strength
Market strength indicators help investors to evaluate how Cytokinetics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cytokinetics shares will generate the highest return on investment. By undertsting and applying Cytokinetics stock market strength indicators, traders can identify Cytokinetics entry and exit signals to maximize returns
Cytokinetics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cytokinetics' price direction in advance. Along with the technical and fundamental analysis of Cytokinetics Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cytokinetics to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1219 | |||
| Jensen Alpha | 0.3726 | |||
| Total Risk Alpha | 0.1476 | |||
| Sortino Ratio | 0.149 | |||
| Treynor Ratio | 0.3844 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytokinetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For more information on how to buy Cytokinetics Stock please use our How to buy in Cytokinetics Stock guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. If investors know Cytokinetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytokinetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.30) | Revenue Per Share | Quarterly Revenue Growth 3.181 | Return On Assets | Return On Equity |
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytokinetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytokinetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytokinetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.